Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: The axtell regimen

1. Verschraegen, C.F.
2. Arias-pulido, H.
3. Lee, S.-J.
4. Movva, S.
5. Cerilli, L.A.
6. Eberhardt, S.
7. Schmit, B.
8. Quinn, R.
9. Muller, C.Y.
10. Rabinowitz, I.
11. Purdy, M.
12. Snyder, D.
13. Bocklage, T.